KRT5 and ovarian carcinoma: A recent study by Corr et al (2015) demonstrating that K5+ ovarian cancer cells were more resistant to cisplatin-induced apoptosis than K5- cells has suggested that K5 is a marker of a chemoresistant subpopulation of ovarian cancer cells [50].